Who makes Skyrizi and where is it made?

Drugs.com

Official answer

by Drugs.com

Skyrizi is made by AbbVie Inc., a pharmaceutical company located in North Chicago, Illinois. You can contact AbbVie at 1-800-222-6885 or contact them online at Abbvie.com.

When was Skyrizi approved?

In April 2019 the U.S. Food and Drug Administration (FDA) first approved Skyrizi (risankizumab-rzaa) from Abbvie. It is an interleukin-23 (IL-23) inhibitor for the treatment of plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

In 2021, Skyrizi was also approved to treat active psoriatic arthritis in adults, and in 2022 it was approved for moderate-to-severe Crohn's disease in adults.

  • For plaque psoriasis and psoriatic arthritis, Skyrizi is given as two initiation doses at week 0 and 4 by a subcutaneous (under the skin) injection, then it is given every 12 weeks as a maintenance dose.
  • In Crohn’s Disease, an induction dosage is given via intravenous infusion at Week 0, Week 4, and Week 8. Maintenance dosage is then given by a subcutaneous injection at Week 12, then every 8 weeks thereafter.
  • Your doctor can give you the Skyrizi injections at the office, or you (or your caregiver), can learn to give them at home (pre-filled pen or syringe).

    • Does Skyrizi have common side effects?

    Common side effects in plaque psoriasis and psoriatic arthritis include upper respiratory infections, headache, fatigue, injection site reactions and tinea (fungal) infections.

    In Crohn's disease, common side effects include upper respiratory infections, headache, and arthralgia (joint pain) during the induction period, and arthralgia, injection site reactions, abdominal pain, anemia, pyrexia (fever), back pain, arthropathy (joint disease), and urinary tract infection.

    This is not all the information you need to know about Skyrizi (risankizumab-rzaa) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Skyrizi information here, and discuss this information and any questions you have with your doctor or other health care provider.

    Related medical questions

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords